ShockWave Medical, Inc. ( NASDAQ:SWAV ) Sector: Health Technology (Medical Specialties) Market Capitalization: $7.109B Current Price: $198.62 Breakout price: $200.15 Buy Zone (Top/Bottom Range): $194.30-$180.50 Price Target: $217.20-$221.90 (1st), $246.50-$249.80 (2nd) Estimated Duration to Target: 38-40d (1st), 83-88d (2nd) Contract of Interest: $SWAV 8/19/22...
Did a google search on the advancements in medical science and it is said that we are moving at an exceptional rate, doubling in its movement every few months. Graphite Bio is a gene-editing company. Without doing much research on the company itself I know that this area is a sizeable area of research and development for quite some time now and a breakthrough is...
Will the handle form next and then the breakout? Wait and see.
11.29 This is a move as expected The 39,800 won is a strong support line, so I would like to shoot 37,000 won quickly and roll it up in a day. I look forward to buying below.
Based on the graph only, not the company's performance. NOT A FINANCIAL ADVICE !
This has been sitting down here accumulating. This is a company getting its profit from medical patents awaiting FDA approval for its surgical technology that will increase recovery time for patients.... I'm here for it.
Hello my beauties. I think MRNA has entered a distribution range, as the ST (second test) seemed to be pretty weak, and the price is now showing weakness below the trading range. We are going to wait for further developments in price action and eventually take a trade on the final LPSY. For those of you who like trading ranges, this might be a juicy opportunity....
Invitae offers gene panels and single-gene testing for a broad range of clinical areas including hereditary cancer, cardiology, neurology, pediatric genetics, metabolic disorders, immunology, and hematology. The price is on a strong weekly pattern, decent long opportunity on probable bullish rebound.
Just did a basic fib retracement on ISRG using that last low. Looks like the 50 fib line presents a consistent area of traffic and previous support. It tested the 236 fib area weeks ago and after managing to break through and hold, the stock made new highs. After failing to retest those highs at the end of the week, it settled back at the recent levels just shy...
Symbol Update NASDAQ:NVAX
ZOM is a penny stock that trying to make a new high. Price target is 10$
After assessing Sanofi both technically and fundamentally my position on it is a strong buy.
SNDL is maybe going to touch a new support line! Im thinking its more realistic for sndl to touch 0.6$ and then take off huge!
My favorite new indie stock, Seelos Therapeutics, was recently upgraded from a price target of $4.70 to a whopping $15. For this to happen, it may have to beat some bears (in SPY) and sharks (in short interest). Short interest in the stock is down, with most shares not available to short. This is positive and bullish for shorter term. The stock market looks to...
"Ultrasound designed for the future." "Experience a groundbreaking ultrasound solution and the world’s only single-probe, whole-body handheld device, powered by Ultrasound-on-Chip™ technology. Butterfly transforms complex processes into one connected POCUS system to help you offer better, more efficient care."-Butterfly Network Inc That is info from their...
Hi. In this 1D chart I've plotted a few things: the recent MA 56 crossing that marked a trend turn, the approaching resistance zone from November last year and an interpretation of the movements since then as Elliott Waves. You can also see: There is still rooms for the Williams 224 to climb further. The historical volatility is lower than it was in...
"Merging medolife The polarization machine emits electromagnetic (EM) waves in the form of packets of quantum energy (""photons"") with a frequency that resonates with the molecular frequency of targeted compounds"
85% below the July peak of last year and 99% below its all-time high. Orbiting a major support level around $4. A capital injection began in mid-November that is still not properly reflected in price. Stochastic at the oversold point and RSI close to touching it. It could give the surprise of giving a significant bounce to the marked lines. The risk is that...